Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
CAS No. 1233876-42-0
APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)( ——— )
Catalog No. M40887 CAS No. 1233876-42-0
APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAPL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
-
NoteResearch use only, not for human use.
-
Brief DescriptionAPL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
-
DescriptionAPL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1233876-42-0
-
Formula Weight2585.92
-
Molecular FormulaC105H185N31O39S1
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Acetyl shikonin
Acetylshikonin exhibits weak cytotoxicity against human umbilical vein endothelial cells (HUVECs) with IC5 of over 2 microM, exhibits the antiangiogenic and antitumorigenic effects by suppressing proliferation and angiogenic factors.
-
[Val671]-Amyloid b/A...
[Val671]-Amyloid b/A4 Protein Precursor770 (667-676)
-
Glimepiride sulfonam...
Glimepiride sulfonamide is an antiinflammatory agent.
